APA način citiranja (7. izdanje)

(15034782), D. H. O., (15054338), B. B., (15023852), L. W., (15054341), V. S., (15054344), A. G., (15054347), Y. Z., . . . (15054392), B. K. (2025). Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms.

Čikaški stil citiranja (17. izdanje)

(15034782), Dwight H. Owen, et al. Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms. 2025.

MLA način citiranja (9. izdanje)

(15034782), Dwight H. Owen, et al. Supplementary Figure 1 from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms. 2025.